Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Psychopharmacology Bulletin|April 18, 2012
Zonisamide for bipolar disorder, mania or mixed states: a randomized, double blind, placebo-controlled adjunctive trialDeborah Dauphinais, Michael Knable, Joshua Rosenthal, et al.Psychopharmacology Bulletin|October 15, 2016
Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive TrialDeborah Dauphinais, Michael Knable, Joshua Rosenthal, et al.Schizophrenia Bulletin|April 16, 2021
Misreporting of Results of Research in PsychiatryJana Bowcut, Linda Levi, Ortal Livnah, et al.The American Journal of Psychiatry|May 3, 2002
Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophreniaChristopher M Wilk, James M Gold, John J Bartko, et al.Schizophrenia Research|May 1, 2007
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophreniaMark S George, Christine E Molnar, Emily L Grenesko, et al.Schizophrenia Research|June 29, 2007
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophreniaQiwen Mu, Kevin Johnson, Paul S Morgan, et al.Pageof 1